The prevalence of COVID-19-associated diabetes is not the result of a single event but of a
combination of disease susceptibility associated with chronic illness and COVID-19-specific …

With the accumulation of observational data showing an association of metabolic co‐
morbidities with adverse outcomes from COVID‐19, there is a need to disentangle the …

Background The epidemiology of COVID-19 and its association with cardiometabolic
disorders is poorly understood. This is a narrative review that investigates the effects of …

Aims: This study aimed to investigate the clinical courses and outcomes of diabetes mellitus
patients with coronavirus disease 2019 (COVID-19) in Wuhan. Methods: This study enrolled …

The pandemic of coronavirus disease (COVID-19), a disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing substantial morbidity and …

Backgound To figure out whether diabetes is a risk factor influencing the progression and
prognosis of 2019 novel coronavirus disease (COVID‐19). Methods A total of 174 …

Aims After the acute phase of SARS-CoV-2 infection, the onset of glycemic impairment and
diabetes have been reported. Nevertheless, the exact burden of glycemic impairment and …

Abstract Novel coronavirus disease 2019 (COVID‐19), a 2020 pandemic, has resulted in an
unexpected loss in lives, quality of life, and the economy. The COVID‐19 clinical spectrum …

The prevalence of diabetes in people with coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has varied worldwide …

The coronavirus disease 2019 (COVID-19) pandemic has infected> 22.7 million and led to
the deaths of 795,000 people worldwide. Patients with diabetes are highly susceptible to …